Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Economics: Pregnant cardiologists consistently mistreated | Pfizer gains key treatments in $6.7B acquisition
Friday, March 18, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Economics

Pregnant cardiologists are consistently mistreated by employers: 8 key takeaways from a new analysis

A significant number of cardiologists are mistreated—often in more ways than one—after they tell their employer they are pregnant. 

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Pregnant cardiologists are consistently mistreated by employers: 8 key takeaways from a new analysis

Share on Twitter Share on Facebook Share on Linkedin
women doctors
A significant number of cardiologists are mistreated—often in more ways than one—after they tell their employer they are pregnant. 
READ MORE >

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Share on Twitter Share on Facebook Share on Linkedin
Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. 
READ MORE >

Telecardiology during the COVID-19 pandemic showed cardiologists another way to treat patients

Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option. 

READ MORE >
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option.
Share on Twitter Share on Facebook Share on Linkedin

Telecardiology during the COVID-19 pandemic showed cardiologists another way to treat patients

Share on Twitter Share on Facebook Share on Linkedin
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option.
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option. 
READ MORE >

TAVR associated with lower healthcare costs than surgery

Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions. 

READ MORE >
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
Share on Twitter Share on Facebook Share on Linkedin

TAVR associated with lower healthcare costs than surgery

Share on Twitter Share on Facebook Share on Linkedin
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions. 
READ MORE >

Severe financial strain more than doubles risk of death among heart attack patients

Screening for financial strain, researchers wrote, could help identify patients who need additional help.

READ MORE >
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
Share on Twitter Share on Facebook Share on Linkedin

Severe financial strain more than doubles risk of death among heart attack patients

Share on Twitter Share on Facebook Share on Linkedin
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
Screening for financial strain, researchers wrote, could help identify patients who need additional help.
READ MORE >

Cardiology societies want to help Congress reform Medicare

Multiple cardiology societies, including the ACC, ASE and SCAI, want to work with Congress to update Medicare payment policies. 

READ MORE >
The U.S. Congress is working on healthcare legislation to fix medicare reimbursements and end annual cuts to physicians.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology societies want to help Congress reform Medicare

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Congress is working on healthcare legislation to fix medicare reimbursements and end annual cuts to physicians.
Multiple cardiology societies, including the ACC, ASE and SCAI, want to work with Congress to update Medicare payment policies. 
READ MORE >

In Case You Missed It

Hospital pays $3.8M to resolve allegations it assisted cardiologist in exchange for patient referrals

The New Hampshire hospital allegedly received referrals worth "millions of dollars."

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Hospital pays $3.8M to resolve allegations it assisted cardiologist in exchange for patient referrals

Share on Twitter Share on Facebook Share on Linkedin
The New Hampshire hospital allegedly received referrals worth "millions of dollars."
READ MORE >

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme